| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 295.88B | 279.19B | 266.81B | 251.57B | 215.88B |
| Gross Profit | 87.28B | 82.18B | 77.77B | 71.25B | 62.74B |
| EBITDA | 36.73B | 44.89B | 40.28B | 32.33B | 33.35B |
| Net Income | 29.71B | 22.12B | 18.55B | 13.74B | 14.54B |
Balance Sheet | |||||
| Total Assets | 459.78B | 371.51B | 391.30B | 345.88B | 332.62B |
| Cash, Cash Equivalents and Short-Term Investments | 82.92B | 68.72B | 77.92B | 59.58B | 55.44B |
| Total Debt | 52.59B | 27.24B | 30.86B | 35.62B | 39.23B |
| Total Liabilities | 155.97B | 109.35B | 130.74B | 119.29B | 122.86B |
| Stockholders Equity | 296.36B | 259.81B | 258.40B | 224.40B | 207.76B |
Cash Flow | |||||
| Free Cash Flow | 16.13B | 8.14B | 27.74B | 12.43B | 13.00B |
| Operating Cash Flow | 31.89B | 21.30B | 38.58B | 21.35B | 21.00B |
| Investing Cash Flow | -8.98B | -11.83B | -9.16B | -9.28B | -9.07B |
| Financing Cash Flow | -20.24B | -21.66B | -15.70B | -9.96B | -7.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥282.74B | 7.78 | 8.91% | 3.85% | 5.98% | 39.06% | |
74 Outperform | ¥621.37B | 20.53 | 5.25% | 2.13% | -7.11% | 68.57% | |
71 Outperform | ¥108.41B | 15.48 | ― | 4.64% | 1.98% | -17.68% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥6.59B | 2.15 | ― | 1.37% | -5.11% | 29.29% | |
56 Neutral | ¥798.26B | 28.52 | 1.88% | 6.16% | 1.98% | -48.28% | |
55 Neutral | ¥630.52B | 203.90 | 5.94% | 0.56% | 7.03% | -53.53% |